Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fuad El Rassi

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Transfusion|March 11, 2018
Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failureCheryl L Maier, Phillip J Gross, Christina L Dean, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 17, 2017
Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to ImatinibVamsi K Kota, Jee Hyun Kong, Martha Arellano, et al.
Journal of Clinical Medicine|May 24, 2020
Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase InhibitorsJee Hyun Kong, Elliott F Winton, Leonard T Heffner, et al.
Southern Medical Journal|August 2, 2014
Incidence and geographic distribution of adult acute leukemia in the state of GeorgiaFuad El Rassi, Kevin C Ward, Christopher R Flowers, et al.
Cancer|August 8, 2013
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignanciesAna G Antun, Shannon Gleason, Martha Arellano, et al.
Leukemia & Lymphoma|October 19, 2013
Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphomaZahi Mitri, Momin T Siddiqui, Fuad El Rassi, et al.
Cancer|February 28, 2017
Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?Jee Hyun Kong, Elliott F Winton, Leonard T Heffner, et al.
Pain|April 22, 2026
A prospective study of high-impact chronic pain in sickle cell disease: the Sickle Pain-Related Impact (SPiRIt) studyAshna Jagtiani, Ashleigh Hawk, Cynthia Sinha, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2016
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?Zachariah DeFilipp, Amelia A Langston, Zhengjia Chen, et al.
American Journal of Hematology|August 6, 2024
Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysisStaci D Arnold, Nitya Bakshi, Diana Ross, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Transfusion|March 11, 2018
Transfusion-transmitted malaria masquerading as sickle cell crisis with multisystem organ failureCheryl L Maier, Phillip J Gross, Christina L Dean, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 17, 2017
Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to ImatinibVamsi K Kota, Jee Hyun Kong, Martha Arellano, et al.
Journal of Clinical Medicine|May 24, 2020
Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase InhibitorsJee Hyun Kong, Elliott F Winton, Leonard T Heffner, et al.
Southern Medical Journal|August 2, 2014
Incidence and geographic distribution of adult acute leukemia in the state of GeorgiaFuad El Rassi, Kevin C Ward, Christopher R Flowers, et al.
Cancer|August 8, 2013
Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignanciesAna G Antun, Shannon Gleason, Martha Arellano, et al.
Leukemia & Lymphoma|October 19, 2013
Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphomaZahi Mitri, Momin T Siddiqui, Fuad El Rassi, et al.
Cancer|February 28, 2017
Does the frequency of molecular monitoring after tyrosine kinase inhibitor discontinuation affect outcomes of patients with chronic myeloid leukemia?Jee Hyun Kong, Elliott F Winton, Leonard T Heffner, et al.
Pain|April 22, 2026
A prospective study of high-impact chronic pain in sickle cell disease: the Sickle Pain-Related Impact (SPiRIt) studyAshna Jagtiani, Ashleigh Hawk, Cynthia Sinha, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2016
Does Post-Transplant Maintenance Therapy With Tyrosine Kinase Inhibitors Improve Outcomes of Patients With High-Risk Philadelphia Chromosome-Positive Leukemia?Zachariah DeFilipp, Amelia A Langston, Zhengjia Chen, et al.
American Journal of Hematology|August 6, 2024
Long-term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysisStaci D Arnold, Nitya Bakshi, Diana Ross, et al.
Pageof 4